Yeh Chen Lee

Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial

Linda Mileshkin, Kathleen N. Moore, Elizabeth H Barnes et al. · The Lancet Oncology · 2023 · 190 citations · Full text

Medicine, Oncology, Radiation Oncology +16

EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression

Stéphanie Lheureux, Ana Oaknin, Swati Garg et al. · Clinical Cancer Research · 2020 · 132 citations · Full text

Medicine, Oncology, Pharmacology +16

Clinical activity of durvalumab for patients with advanced mismatch repair-deficient and repair-proficient endometrial cancer. A nonrandomized phase 2 clinical trial

Yoland Antill, Peey‐Sei Kok, Kristy Robledo et al. · Journal for ImmunoTherapy of Cancer · 2021 · 129 citations · Full text

Medicine, Gynecology, Oncology +13

Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial

Nicoletta Colombo, Elena Biagioli, Kenichi Harano et al. · The Lancet Oncology · 2024 · 114 citations

Medicine, Oncology, Pharmacotherapy +7

Tumor Angiogenesis Correlates With Histologic Type and Metastasis in Non-Small-Cell Lung Cancer

Ang Yuan, Pan‐Chyr Yang, Chong‐Jen Yu et al. · American Journal of Respiratory and Critical Care Medicine · 1995 · 104 citations

Medicine, Oncology, Pathology +17